Keeps Biopharma Inc. (KOSDAQ:256940)
South Korea · Delayed Price · Currency is KRW 8,460.00
-130.00 (-1.51%)
At close: Apr 17, 2026
Keeps Biopharma Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -9,785 | 1,113 | 3,930 | -11,375 | -15,317 |
Depreciation & Amortization | 4,488 | 2,582 | 1,442 | 993.33 | 812.4 |
Loss (Gain) From Sale of Assets | 46.89 | -24.15 | 77.46 | -52.48 | -19.15 |
Asset Writedown & Restructuring Costs | - | 383.84 | - | - | - |
Loss (Gain) From Sale of Investments | 2,633 | -847.49 | -1,077 | 177.95 | 2,519 |
Loss (Gain) on Equity Investments | 1,720 | 1,609 | -4,930 | 3,998 | 3,081 |
Stock-Based Compensation | - | - | 269.1 | 509.97 | 1,458 |
Provision & Write-off of Bad Debts | -923.58 | -1,343 | 70.84 | 912.84 | 2,926 |
Other Operating Activities | 4,496 | 5,258 | 5,255 | 565.12 | -2,073 |
Change in Accounts Receivable | -3,920 | -963.41 | -622.46 | 561.76 | -1,447 |
Change in Inventory | -11,178 | -4,816 | -696.77 | 0.6 | -1,997 |
Change in Accounts Payable | -2,010 | -1,090 | 1,224 | -138.22 | 611.5 |
Change in Other Net Operating Assets | -488.16 | 2,945 | -4,999 | 2,980 | 1,066 |
Operating Cash Flow | -14,921 | 4,808 | -57.13 | -866.26 | -8,380 |
Capital Expenditures | -31,933 | -6,596 | -990.97 | -95.85 | -90.75 |
Sale of Property, Plant & Equipment | 1,621 | 27.18 | 24.18 | 30.31 | 38.3 |
Cash Acquisitions | -5,339 | -17,812 | -26,610 | - | - |
Sale (Purchase) of Intangibles | -2,864 | -104.49 | -79.79 | -33.96 | -32.2 |
Investment in Securities | 137.99 | 100.66 | 682.22 | -3,199 | -11,484 |
Other Investing Activities | -446.73 | 456.64 | 992.3 | -4,784 | -88.42 |
Investing Cash Flow | -40,297 | -22,275 | -27,591 | -9,427 | -14,276 |
Short-Term Debt Issued | 4,501 | 500 | 19,000 | - | 3,000 |
Long-Term Debt Issued | 59,093 | 12,012 | 3,000 | - | 32,000 |
Total Debt Issued | 63,594 | 12,512 | 22,000 | - | 35,000 |
Short-Term Debt Repaid | -790.02 | -6,000 | -13,000 | - | -7,000 |
Long-Term Debt Repaid | -555.05 | -6,234 | -248.51 | -3,327 | -330.69 |
Total Debt Repaid | -1,345 | -12,233 | -13,249 | -3,327 | -7,331 |
Net Debt Issued (Repaid) | 62,249 | 278.15 | 8,751 | -3,327 | 27,669 |
Issuance of Common Stock | 1,199 | - | - | 353.55 | 398.18 |
Other Financing Activities | -4,910 | 31,649 | -600 | -298 | -35.68 |
Financing Cash Flow | 58,537 | 31,927 | 8,151 | -3,272 | 28,032 |
Foreign Exchange Rate Adjustments | -53.2 | 210.67 | -21.75 | -6.82 | 673.45 |
Net Cash Flow | 3,266 | 14,671 | -19,519 | -13,572 | 6,049 |
Free Cash Flow | -46,854 | -1,787 | -1,048 | -962.12 | -8,471 |
Free Cash Flow Margin | -27.54% | -1.40% | -1.14% | -6.58% | -198.82% |
Free Cash Flow Per Share | -2389.34 | -94.70 | -55.71 | -51.34 | -489.19 |
Cash Interest Paid | 1,814 | 1,326 | 1,360 | - | 79.71 |
Cash Income Tax Paid | 2,279 | 13.85 | 14.57 | 137.28 | 43.29 |
Levered Free Cash Flow | -61,118 | 21,450 | -12,423 | 23.1 | -9,364 |
Unlevered Free Cash Flow | -56,640 | 23,782 | -11,154 | 607.29 | -8,308 |
Change in Working Capital | -17,596 | -3,924 | -5,095 | 3,405 | -1,766 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.